Literature DB >> 6277201

Evidence for two distinct modalities of CA2+ influx into pancreatic B cell.

P Lebrun, W J Malaisse, A Herchuelz.   

Abstract

The pathways through which glucose stimulates Ca2+ inflow into islet cells were investigated by comparing the inhibitory effect of verapamil, a selective blocker of voltage-sensitive Ca2+ channels, on glucose- and K+-stimulated insulin release and 45Ca efflux from perifused rat pancreatic islets. The islets stimulated by K+ (20 mM) were more sensitive to verapamil than those exposed to glucose (27.8 mM). The stimulation of 45Ca efflux by a low concentration of glucose (8.3 mM) was extremely resistant to verapamil, whereas that induced by a rise in the glucose concentration from 8.3 to 27.8 mM displayed the same sensitivity towards verapamil as that characterizing the response to K+. Because the increase in 45Ca efflux evoked by glucose or K+. Because the increase in 45Ca efflux evoked by glucose or K+ reflects a stimulation of Ca2+ entry into islet cells, it is proposed that the B cell may be equipped with two populations of Ca2+ channels that differ in their sensitivity towards verapamil and possibly their voltage-dependency. Glucose apparently stimulates Ca2+ inflow through both types of channels. At low concentrations, glucose may stimulate Ca2+ inflow, in part, by gating the voltage-insensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277201     DOI: 10.1152/ajpendo.1982.242.1.E59

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone.

Authors:  J de Weille; H Schmid-Antomarchi; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 2.  Pharmacology and regulation of ATP-sensitive K+ channels.

Authors:  J R de Weille; M Fosset; C Mourre; H Schmid-Antomarchi; H Bernardi; M Lazdunski
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

3.  Depolarization of rat basophilic leukemia cells inhibits calcium uptake and exocytosis.

Authors:  F C Mohr; C Fewtrell
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

4.  High [K+] alters the stimulus-hydrosmotic response coupling in toad bladder.

Authors:  A Grosso; R C de Sousa
Journal:  Pflugers Arch       Date:  1984-04       Impact factor: 3.657

5.  Dynamics of the cationic, bioelectrical and secretory responses to formycin A in pancreatic islet cells.

Authors:  P Lebrun; E Renström; M H Antoine; K Bokvist; M Holmquist; P Rorsman; W J Malaisse
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

6.  Ionic determinants of bioelectrical spiking activity in the pancreatic B-cell.

Authors:  W J Malaisse; P Lebrun; A Herchuelz
Journal:  Pflugers Arch       Date:  1982-11-11       Impact factor: 3.657

7.  Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues.

Authors:  B Becker; M H Antoine; Q A Nguyen; B Rigo; K E Cosgrove; P D Barnes; M J Dunne; B Pirotte; P Lebrun
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  Tricyclic antidepressant imipramine reduces the insulin secretory rate in islet cells of Wistar albino rats through a calcium antagonistic action.

Authors:  M-H Antoine; D Gall; S N Schiffmann; P Lebrun
Journal:  Diabetologia       Date:  2004-04-16       Impact factor: 10.122

9.  Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.

Authors:  D Delmeire; D Flamez; S A Hinke; J J Cali; D Pipeleers; F Schuit
Journal:  Diabetologia       Date:  2003-09-17       Impact factor: 10.122

10.  Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.

Authors:  N G Morgan; C D Short; G M Rumford; W Montague
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.